top of page
GF-203
GF-203 is our follow-on protein therapeutic targeting similar indications as GF-103. Currently in early development stage, this strategic asset strengthens our pipeline depth in inflammatory and degenerative diseases
GF-203 Development Status
GF-203 represents our strategic expansion into next-generation protein therapeutics across similar therapeutic areas as GF-103. As this program is currently in early development stages, detailed information regarding mechanism of action, preclinical data, and development timelines will be disclosed as the program advances through key development milestones.
We are committed to providing comprehensive updates on GF-203's progress as we achieve significant development benchmarks and regulatory clearances.
bottom of page